Boardroom Alpha
Boardroom Alpha
CMCO · Current Report (Form 8-K) · Filed August 18, 2026

Columbus Mckinnon Corp — Current Report (Form 8-K)

Form
8-K
Filed
August 18, 2026
Period
Aug 14, 2026
Ticker
CMCO
Accession
0001005229-26-000052
Boardroom Alpha · Filing insights

Shareholders approved the first amendment to the Columbus McKinnon Second A&R 2016 LTIP at the 2026 Annual Meeting.

About Columbus Mckinnon Corp
Market cap
$455M
1Y TSR
+19.1%
3Y TSR
−20.3%
Board grade
C+
Sector
Industrials
CEO
David J Wilson
Last annual meeting: Aug 14, 2026 · View full Columbus Mckinnon Corp profile →
cmco-20260814

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT

Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 14, 2026

COLUMBUS McKINNON CORPORATION
(Exact name of registrant as specified in its charter)

New York
(State or other jurisdiction of incorporation)
001-3436216-0547600
(Commission File Number)(IRS Employer Identification No.)
 
13320 Ballantyne Corporate Place, Suite DCharlotteNC28277
(Address of principal executive offices)(Zip Code)

Registrant's telephone number including area code: (716) 689-5400
 
_________________________________________________
(Former name or former address, if changed since last report)


Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.01 par value per shareCMCONasdaq Global Select Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging Growth Company

If an Emerging Growth Company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




Item 5.02DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS
(e) At the 2026 annual meeting of shareholders (the “Annual Meeting”) of Columbus McKinnon Corporation (the “Company”) held on August 14, 2026, the Company’s shareholders approved the first amendment (the “Amendment”) to the Columbus McKinnon Corporation Second Amended and Restated 2016 Long Term Incentive Plan. The Company’s Board of Directors had previously approved the Amendment on June 1, 2026, subject to receipt of shareholder approval. A description of the Amendment was set forth in the Company’s 2026 definitive proxy statement filed with the Securities and Exchange Commission on June 26, 2026 under the heading “Proposal 4: Approve an Amendment to the Second A&R 2016 LTIP,” which description is incorporated herein by reference. Such description is qualified in its entirety by reference to the full text of the Amendment, a copy of which is attached to this Current Report on Form 8-K as Exhibit 10.1 and incorporated by reference herein.

Item 5.07SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

On August 14, 2026, the Company held its Annual Meeting.

At the Annual Meeting, shareholders approved each of management’s proposals, which consisted of: (i) the election of twelve (12) directors, each of whom will serve as directors of the Company for terms of one (1) year and until their successors are elected and qualified; (ii) the approval of the advisory vote on executive compensation; (iii) the ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for fiscal year 2027; and (iv) the approval of the Amendment.

Proposal 1: Election of Directors

The following table reflects the tabulation of the votes with respect to each director who was elected at the Annual Meeting. Each director received a majority vote.

NameVotes ForVotes AgainstVotes WithheldBroker Non-Vote
Chad R. Abraham40,277,983 112,126 4,946 4,649,911 
Aziz S. Aghili38,758,024 1,631,493 5,538 4,649,911 
Jeanne Beliveau-Dunn40,104,692 282,977 7,386 4,649,911 
Kathryn V. Roedel40,134,140 254,324 6,591 4,649,911 
Andrew Campelli39,937,926 66,631 390,498 4,649,911 
Gerald G. Colella40,247,817 142,180 5,058 4,649,911 
Michael Dastoor39,058,276 1,329,907 6,872 4,649,911 
Michael Lamach40,260,023 128,573 6,459 4,649,911 
Nathan K. Sleeper39,937,846 66,402 390,807 4,649,911 
Chris J. Stephens, Jr.40,300,620 88,386 6,049 4,649,911 
David J. Wilson40,244,835 144,781 5,439 4,649,911 
Rebecca Yeung40,132,673 236,385 25,997 4,649,911 

Proposal 2: Advisory Vote on Executive Compensation

The following table reflects the tabulation of the votes with respect to the approval of the advisory vote on executive compensation:

Votes ForVotes AgainstAbstainedBroker Non-Vote
39,528,851666,321199,8834,649,911 

Proposal 3: Ratification of Appointment of Independent Registered Public Accounting Firm

The following table reflects the tabulation of the votes with respect to the ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for fiscal year 2027:



Votes ForVotes AgainstAbstainedBroker Non-Vote
44,464,798546,50533,663

Proposal 4: Vote to Approve the Amendment

The following table reflects the tabulation of the votes with respect to approval of the Amendment:

Votes ForVotes AgainstAbstainedBroker Non-Vote
39,580,597691,129123,3294,649,911 
Item 9.01FINANCIAL STATEMENTS AND EXHIBITS.
(d)  Exhibits.

EXHIBIT
NUMBER
  DESCRIPTION
      
First Amendment to the Columbus McKinnon Corporation Second Amended and Restated 2016 Long Term Incentive Plan (incorporated by reference to Exhibit A to the Company’s Definitive Proxy Statement on Schedule 14A filed on June 26, 2026).
104Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

COLUMBUS McKINNON CORPORATION
  
By:/s/ Alan S. Korman
Name:Alan S. Korman
Title:Senior Vice President, General Counsel, Corp. Development and Secretary


Dated: August 18, 2026

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Columbus Mckinnon Corp (CMCO)

Reference

Frequently asked questions

When did Columbus Mckinnon Corp file this 8-K?
Columbus Mckinnon Corp (CMCO) filed this Current Report (Form 8-K) with the SEC on August 18, 2026. The accession number assigned by EDGAR is 0001005229-26-000052.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Shareholders approved the first amendment to the Columbus McKinnon Second A&R 2016 LTIP at the 2026 Annual Meeting. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Columbus Mckinnon Corp's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Columbus Mckinnon Corp has filed under CIK 1005229, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer